Martinez-Ubieto, J.
Aragón- Benedí, C.
de Pedro, J.
Cea-Calvo, L.
Morell, A.
Jiang, Y.
Cedillo, S.
Ramírez-Boix, P.
Pascual-Bellosta, A. M.
Funding for this research was provided by:
MSD Spain
Article History
Received: 16 July 2020
Accepted: 18 January 2021
First Online: 16 February 2021
Ethics approval and consent to participate
: Access to non-publicly available databases used in the analysis (eSalud and BotPlus) were obtained by subscription. This was a non-clinical study that did not collect information from individuals, and ethic committee approval or informed consent was not necessary.
: Not applicable.
: MSD Spain and Merck & Co. employees participated in the model design, analysis, interpretation of data and writing of the manuscript. JY is employee of MSD Ltd., UK, and may own stock and/or hold stock options in Merck & Co., Inc., Kenilworth, NJ, USA. PJ, RBP and CCL are employees of MSD, Spain. CS is an employee of Covance Clinical Development, a contract research organization providing support to MSD, Spain. MUJ, ABC, PBAM and MA declare NO competing interests.